The estimated Net Worth of Anthony Hayes is at least $2.22 Millón dollars as of 14 December 2022. Mr Hayes owns over 4,500 units of Spherix stock worth over $628,984 and over the last 11 years he sold AIKI stock worth over $500,000. In addition, he makes $1,095,341 as CEO, Principal Financial Officer y Principal Accounting Officer & Director at Spherix.
Mr has made over 19 trades of the Spherix stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 4,500 units of AIKI stock worth $16,605 on 14 December 2022.
The largest trade he's ever made was selling 400,000 units of Spherix stock on 26 May 2020 worth over $500,000. On average, Mr trades about 20,191 units every 117 days since 2014. As of 14 December 2022 he still owns at least 176,681 units of Spherix stock.
You can see the complete history of Mr Hayes stock trades at the bottom of the page.
Anthony C. Hayes Esq. is the CEO, Principal Financial Officer, Principal Accounting Officer & Director at Spherix.
As the CEO, Principal Financial Officer y Principal Accounting Officer & Director of Spherix, the total compensation of Mr Esq at Spherix is $1,095,341. There are no executives at Spherix getting paid more.
Mr Esq is 53, he's been the CEO, Principal Financial Officer y Principal Accounting Officer & Director of Spherix since . There are no older and no younger executives at Spherix.
Anthony's mailing address filed with the SEC is ONE ROCKEFELLER PLAZA,, 11TH FLOOR, NEW YORK, NY, 10020.
Over the last 21 years, insiders at Spherix have traded over $0 worth of Spherix stock and bought 348,588 units worth $1,675,179 . The most active insiders traders include Anthony Hayes, Soo Yu y Kyle Michael Wool. On average, Spherix executives and independent directors trade stock every 85 days with the average trade being worth of $32,656. The most recent stock trade was executed by Kyle Michael Yu Soo Wool on 19 December 2022, trading 5,000 units of AIKI stock currently worth $17,950.
Spherix, Inc. is a biotechnology development company, which engages in the provision of diversified commercialization platform for protected technologies. The firm's activities include the acquisition and development of patents through internal or external research and development. Its patent portfolio consists of patents in the fields of wireless communications, satellite, solar and radio frequency, as well as 2 U.S. patents in pharmaceutical technology. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.
Spherix executives and other stock owners filed with the SEC include: